![](https://reachora-public-videos.imgix.net/v/24/0/5/498529-0a5e-4756-bf94-c204cd9b3b3e/thumbnails/image_0.jpg)
![](https://reachora-public-videos.imgix.net/v/24/3/7/8443a3-6710-420a-9676-b77656f7245a/thumbnails/image_1.jpg)
![](https://reachora-public-videos.imgix.net/v/2/7/f/c118f1-9476-44b7-af15-441123e112b6/thumbnails/image_5.jpg)
![](https://reachora-public-thumbnails.imgix.net/uploaded/production/0af5361e-6d7b-4008-8c5f-d1ae91b9c28b.png)
![](https://reachora-public-videos.imgix.net/v/24/4/3/871c05-ecbd-4ef3-be08-b271e306326f/thumbnails/image_1.jpg)
![](https://reachora-public-videos.imgix.net/v/24/d/6/3c22e3-f5d8-487d-b8b1-a4dc8347c054/thumbnails/image_2.jpg)
- Coronary Physiology
- Fractional Flow Reserve (FFR)
- Instantaneous wave-Free Ratio (iFR)
- Percutaneous Coronary Interventions (PCI)
- Stable Coronary Artery Disease (CAD)
Should We Need Stenting at all? ORBITA Study - Dr. Rasha Al-Lamee
Summary
Dr Rasha Al-Lamee discusses the potential outcome and implications for PCI from ORBITA.
Key learning points:
•To review the current evidence for treatment of stable angina
•To reviewthe...
Summary
Dr Rasha Al-Lamee discusses the potential outcome and implications for PCI from ORBITA.
Key learning points:
•To review the current evidence for treatment of stable angina
•To reviewthe rationale for the ORBITA trial
•To overview the ORBITA trial methodology
Simple Education, is a leading provider of coronary physiology and intracoronary imaging courses to aid treatment of complex coronary artery disease.